Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis.

Saved in:
Bibliographic Details
Title: Population Pharmacokinetic Modeling of Cefepime, Meropenem, and Piperacillin-Tazobactam in Patients With Cystic Fibrosis.
Authors: Rolsma SL; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Sokolow A; Division of Pediatric Pulmonary Medicine, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Patel PC; Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tennessee., Sokolow K; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Jimenez-Truque N; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Fissell WH; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Ryan V; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee., Kirkpatrick CM; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia., Nation RL; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia., Gu K; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Teresi M; Department of Internal Medicine, University of Iowa, Iowa City, Iowa., Fishbane N; The Emmes Company LLC, Rockville, Maryland., Kontos M; The Emmes Company LLC, Rockville, Maryland., An G; Department of Internal Medicine, University of Iowa, Iowa City, Iowa., Winokur P; Department of Internal Medicine, University of Iowa, Iowa City, Iowa., Landersdorfer CB; Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia., Creech CB; Vanderbilt Vaccine Research Program, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.; Division of Pediatric Infectious Diseases, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Source: The Journal of infectious diseases [J Infect Dis] 2025 Feb 20; Vol. 231 (2), pp. e364-e374.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6613
DOI:10.1093/infdis/jiae451